company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17101000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17101000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,532000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2046000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11614000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11614000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,883000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11574000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18800000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18800000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,570000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1789000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11341000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11341000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,909000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10476000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22927000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22927000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,536000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1495000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,60389000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,39493000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,39493000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1272000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1272000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1272000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 17:18:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40736000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,55486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,525000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1778000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-65122000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7333000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7333000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1047000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1047000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1047000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6249000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11432000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11432000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,520000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1422000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4118000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5372000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5372000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,50000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,50000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,915000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,915000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,915000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4407000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10746000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10746000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,485000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1667000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,193000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8401000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8401000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,492000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,492000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,492000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7893000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13086000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13086000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,472000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2516000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3696000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13794000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13794000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-518000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,124000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-294000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-294000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,82000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,82000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:42:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14006000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10720000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10720000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,300000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2063000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8295000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8295000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,139000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-74000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-74000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8279000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11301000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11301000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,291000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,864000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3321000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6825000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6825000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,105000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,77000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,77000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6724000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-324000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-324000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,261000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,766000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6433000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5730000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5730000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,110000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23348000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23458000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23458000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17742000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11258000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11258000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,277000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,674000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4756000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5551000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5551000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,86000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1888000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2039000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2039000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-45000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-42000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-42000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 10:40:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3554000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12263000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12263000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,318000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1684000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1651000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11912000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11912000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1006000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1006000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34843000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23937000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10500000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10500000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,759000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,615000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8947000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8947000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,49000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5236000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5304000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5304000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3624000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8551000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8551000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,165000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1190000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2501000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9697000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9697000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,21000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9737000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9313000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9313000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,144000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,730000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-876000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9315000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9315000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,46000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37455000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37455000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37455000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 14:32:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28176000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11073000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11073000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,133000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1365000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,910000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8665000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8665000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,30000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8689000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36975000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36975000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,142000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,921000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-37948000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,52000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-207000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-207000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-117000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12179000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12179000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,126000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2991000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,40678000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,31616000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,31616000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-387000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2400000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2028000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2028000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,37459000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37031000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,428000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,428000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34072000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10254000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10254000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,132000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,755000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1515000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10882000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10882000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,61000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,61000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,61000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:32:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10872000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11697000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11697000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1438000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1119000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9011000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9011000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-180000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-165000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-165000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,55000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9121000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10014000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10014000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,137000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,511000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-392000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9758000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9758000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,29000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,899000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,899000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,899000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8871000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7154000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7154000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,242000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3741000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6202000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6296000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6296000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,430000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,430000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,430000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,17000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16335000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12673000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12673000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,751000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,464000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3491000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7967000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7967000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-607000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,113000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-494000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-494000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,33000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:51:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8428000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5657000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5657000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,747000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,789000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,583000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3538000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3538000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2128000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,201000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1927000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1927000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-75000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5529000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36282000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36282000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,362000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,414000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1704000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38762000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38762000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-526000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,27000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,499000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38748000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7219000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7219000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,218000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3108000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3846000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7739000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7739000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1025000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1019000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1019000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48650000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,462000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49112000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49112000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,56000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40410000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16360000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16360000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,649000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2722000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12733000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12746000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-145000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,32000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,232000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,232000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,232000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:02:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12627000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16636000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16636000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1659000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2053000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12636000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12623000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-90000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,332000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12381000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15352000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15352000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,998000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1549000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15615000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15615000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-73000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-73000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-73000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15711000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2665000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2665000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,289000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10355000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-392000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13123000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13123000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5026000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5019000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5019000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8110000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4821000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13424000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13424000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,286000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1111000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2229000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14256000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14256000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9524000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9524000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9524000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 16:02:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4748000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15172000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15172000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4239000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10933000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10933000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-486000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2179000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15291000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13112000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13112000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1693000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24357000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24357000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11704000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12653000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12653000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-93000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-93000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1189000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,74825000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,467000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,74103000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,74103000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,61357000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14704000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14704000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,483000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,982000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4329000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8910000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8910000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-222000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-222000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-222000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2022000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2022000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2022000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11154000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4660000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18735000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18735000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,557000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1159000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1500000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18519000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18519000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-491000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8491000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8491000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1037000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1037000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1037000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28047000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:05+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1077000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19700000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19700000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,609000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1062000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2152000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20181000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20181000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1336000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-277000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1613000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1613000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1553000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,267000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1286000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1286000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23080000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1054000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18842000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18842000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,601000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1283000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-213000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17171000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17171000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2638000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2638000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2638000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1290000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1046000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-244000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-244000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20053000.0
Progenics Pharmaceuticals Inc,PGNX,,0000835887,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1015000.0
